Overall outcome. Time to progression (median 1.0 year; 95% CI, 0.7-1.7 years) and overall survival (median 1.6 years; 95% CI, 0.9-2.6 years) from date of brain parenchyma relapse (113 patients, 78 deaths). Symbols indicate censored observations.